UPLOAD Filing
Tonix Pharmaceuticals Holding Corp.
Date: June 16, 2025 · CIK: 0001430306 · Accession: 0000000000-25-006293
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287965
Letter
Re: Tonix Pharmaceuticals Holding Corp. Registration Statement on Form S-3 Filed June 12, 2025 File No. 333-287965 Dear Seth Lederman:
June 16, 2025
Seth Lederman Chief Executive Officer Tonix Pharmaceuticals Holding Corp. 26 Main Street, Suite 101 Chatham, NJ 07928
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Steven M. Skolnick, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 16, 2025 Seth Lederman Chief Executive Officer Tonix Pharmaceuticals Holding Corp. 26 Main Street, Suite 101 Chatham, NJ 07928 Re: Tonix Pharmaceuticals Holding Corp. Registration Statement on Form S-3 Filed June 12, 2025 File No. 333-287965 Dear Seth Lederman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven M. Skolnick, Esq. </TEXT> </DOCUMENT>